Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Tianyu Pharmaceutical Co., Ltd.

Why is Zhejiang Tianyu Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 3.52% and Operating profit at -26.66% over the last 5 years

With a growth in Net Sales of 5.84%, the company declared Very Positive results in Mar 25

The company has declared positive results for the last 2 consecutive quarters
OPERATING CASH FLOW(Y) Highest at CNY 261.35 MM
ROCE(HY) Highest at 2.87%
RAW MATERIAL COST(Y) Fallen by -18.1% (YoY)

With ROE of 4.15%, it has a fair valuation with a 1.44 Price to Book Value

Over the past year, while the stock has generated a return of 45.49%, its profits have risen by 605.8% ; the PEG ratio of the company is 0.1
At the current price, the company has a high dividend yield of 0.3

Market Beating Performance

The stock has generated a return of 45.49% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.18%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Zhejiang Tianyu Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Tianyu Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhejiang Tianyu Pharmaceutical Co., Ltd.

41.48%

0.83

43.04%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.52%

EBIT Growth (5y)

-26.66%

EBIT to Interest (avg)

25.90

Debt to EBITDA (avg)

3.71

Net Debt to Equity (avg)

0.48

Sales to Capital Employed (avg)

0.45

Tax Ratio

11.00%

Dividend Payout Ratio

30.77%

Pledged Shares

Institutional Holding

ROCE (avg)

5.24%

ROE (avg)

4.61%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.44

EV to EBIT

40.74

EV to EBITDA

13.49

EV to Capital Employed

1.29

EV to Sales

2.42

PEG Ratio

0.06

Dividend Yield

0.33%

ROCE (Latest)

3.17%

ROE (Latest)

4.15%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

27What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 261.35 MM

ROCE(HY)

Highest at 2.87%

RAW MATERIAL COST(Y)

Fallen by -18.1% (YoY

NET SALES(Q)

Highest at CNY 754.16 MM

PRE-TAX PROFIT(Q)

Highest at CNY 95.89 MM

NET PROFIT(Q)

Highest at CNY 85.92 MM

EPS(Q)

Highest at CNY 0.25

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Zhejiang Tianyu Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 95.89 MM has Grown at 461.6%

over average net sales of the previous four periods of CNY 17.07 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 85.92 MM has Grown at 691.92%

over average net sales of the previous four periods of CNY 10.85 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 261.35 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 754.16 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 95.89 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 85.92 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.25

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -18.1% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales